• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

In-hospital bleeding events in acute coronary syndrome patients undergoing percutaneous coronary intervention in the era of novel P2Y12 inhibitors: insights from the GReek AntiPlatelet rEgistry-GRAPE.

作者信息

Xanthopoulou Ioanna, Deftereos Spyridon, Sitafidis George, Kanakakis Ioannis, Hamilos Michalis, Karayannis George, Angelidis Christos, Stavrou Katerina, Vavuranakis Manolis, Goudevenos John A, Stefanadis Christodoulos, Alexopoulos Dimitrios

机构信息

Patras University Hospital, Department of Cardiology, Patras, Greece.

Athens General Hospital "G. Gennimatas", Department of Cardiology, Athens, Greece.

出版信息

Int J Cardiol. 2014 Jun 1;174(1):160-2. doi: 10.1016/j.ijcard.2014.03.161. Epub 2014 Mar 28.

DOI:10.1016/j.ijcard.2014.03.161
PMID:24726352
Abstract
摘要

相似文献

1
In-hospital bleeding events in acute coronary syndrome patients undergoing percutaneous coronary intervention in the era of novel P2Y12 inhibitors: insights from the GReek AntiPlatelet rEgistry-GRAPE.新型P2Y12抑制剂时代接受经皮冠状动脉介入治疗的急性冠状动脉综合征患者的院内出血事件：来自希腊抗血小板注册研究-GRAPE的见解
Int J Cardiol. 2014 Jun 1;174(1):160-2. doi: 10.1016/j.ijcard.2014.03.161. Epub 2014 Mar 28.
2
Implementation of contemporary oral antiplatelet treatment guidelines in patients with acute coronary syndrome undergoing percutaneous coronary intervention: a report from the GReek AntiPlatelet rEgistry (GRAPE).急性冠状动脉综合征行经皮冠状动脉介入治疗患者中当代口服抗血小板治疗指南的实施：来自希腊抗血小板登记研究（GRAPE）的报告。
Int J Cardiol. 2013 Oct 15;168(6):5329-35. doi: 10.1016/j.ijcard.2013.08.007. Epub 2013 Aug 15.
3
Dyspnea in patients treated with P2Y receptor antagonists: insights from the GReek AntiPlatElet (GRAPE) registry.接受 P2Y 受体拮抗剂治疗的患者的呼吸困难：来自希腊抗血小板（GRAPE）登记处的见解。
Platelets. 2017 Nov;28(7):691-697. doi: 10.1080/09537104.2016.1265919. Epub 2017 Feb 2.
4
In-hospital switching of oral P2Y12 inhibitor treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention: prevalence, predictors and short-term outcome.经皮冠状动脉介入治疗的急性冠状动脉综合征患者住院期间口服 P2Y12 抑制剂治疗的转换：发生率、预测因素和短期结局。
Am Heart J. 2014 Jan;167(1):68-76.e2. doi: 10.1016/j.ahj.2013.10.010. Epub 2013 Oct 22.
5
Individualizing Duration of Dual Antiplatelet Therapy After Acute Coronary Syndrome or Percutaneous Coronary Intervention.急性冠状动脉综合征或经皮冠状动脉介入治疗后双联抗血小板治疗疗程的个体化
Circulation. 2016 May 24;133(21):2094-8. doi: 10.1161/CIRCULATIONAHA.115.021158.
6
New antiplatelet agents in the treatment of acute coronary syndromes.新型抗血小板药物治疗急性冠脉综合征。
Arch Cardiovasc Dis. 2014 Mar;107(3):178-87. doi: 10.1016/j.acvd.2014.01.009. Epub 2014 Mar 11.
7
Elderly patients with acute coronary syndromes managed without revascularization: insights into the safety of long-term dual antiplatelet therapy with reduced-dose prasugrel versus standard-dose clopidogrel.未进行血运重建治疗的急性冠状动脉综合征老年患者：探讨长期应用小剂量普拉格雷双联抗血小板治疗与标准剂量氯吡格雷相比的安全性。
Circulation. 2013 Aug 20;128(8):823-33. doi: 10.1161/CIRCULATIONAHA.113.002303. Epub 2013 Jul 12.
8
Antiplatelet therapy during perioperative period: double-edged sword.
J Cardiol. 2014 Nov;64(5):331-3. doi: 10.1016/j.jjcc.2014.04.007. Epub 2014 May 23.
9
P2Y12 inhibitors in acute coronary syndrome: when to give them and when to prolong their use.急性冠状动脉综合征中的P2Y12抑制剂：何时给药以及何时延长使用时间。
J Cardiovasc Med (Hagerstown). 2018 Feb;19 Suppl 1:e9-e12. doi: 10.2459/JCM.0000000000000595.
10
Will this trial change my practice? ACCOAST - early loading with a novel P2Y12 inhibitor in patients with an acute coronary syndrome.
EuroIntervention. 2014 Jul;10(3):408-10. doi: 10.4244/EIJV10I3A69.

引用本文的文献

1
Bivalirudin vs. heparin on a background of ticagrelor and aspirin in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: A multicenter prospective cohort study.替格瑞洛和阿司匹林联用背景下，比伐卢定与肝素用于ST段抬高型心肌梗死患者直接经皮冠状动脉介入治疗的多中心前瞻性队列研究
Front Cardiovasc Med. 2022 Oct 28;9:932054. doi: 10.3389/fcvm.2022.932054. eCollection 2022.
2
One-year efficacy and safety of prasugrel and ticagrelor in patients with acute coronary syndromes: Results from a prospective and multicentre ACHILLES registry.普拉格雷和替格瑞洛用于急性冠脉综合征患者的一年疗效与安全性：一项前瞻性多中心ACHILLES注册研究结果
Br J Clin Pharmacol. 2020 Jun;86(6):1052-1061. doi: 10.1111/bcp.14213. Epub 2020 Feb 3.